Canadian Biomanufacturing of Advanced Therapies & Biologics technology R&D partnering mission to the UK — February 26 to March 1, 2024

Sector: Biomanufacturing of advanced therapies and biologics

Subsectors:

• Digital and automation technologies for the development and manufacture of advanced therapies and biologics
• Vaccines (prophylactic, therapeutic, various platforms)
• Therapeutic proteins
• Advanced therapy medicinal products, including messenger RNA, small interfering RNA, gene therapies, cell therapies, engineered tissues
• Other biological based therapies, such as bacteriophage or engineered probiotics
• Viral and non-viral platforms, for example lipid nano particles platforms, including their components and payloads, as delivery systems for proteins and nucleic acids

Open to: Small and medium-sized enterprises

Deadline to apply: December 29, 2023

More information: Consult the detailed request for expression of interest or contact Paul McVeigh, UK Program Co-Lead at paul.mcveigh@nrc-cnrc.gc.ca

Related program: Canadian International Innovation Program